Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
NCT06026514
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
NIH
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL:
B/HPIV3/S-6P
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
[object Object]
[object Object]